Business
Press Release Aug 11 2020
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 11, 2020, titled "Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex�� (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market.".
About this update from Dr. Reddy's Laboratories Ltd.
[{"type":"text","content":" Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 11, 2020, titled \"Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex�� (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market.\". View Attachment","length":453,"tagName":"div"}]